Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2013-05-06 Proxy Solicitation & In…
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
BALCHEM CORP DEF 14A 6-20-2013
Proxy Solicitation & Information Statement
2013-05-06 English
FORM 4
Director's Dealing
2013-05-03 English
BALCHEM CORP 10-Q 3-31-2013
Interim / Quarterly Report Q1 2013
2013-05-03 English
BALCHEM CORPORATION 8-K 5-3-2013
Earnings Release Classification · 95% confidence The document is a Form 8-K filed by Balchem Corporation dated May 3, 2013. It reports earnings for the first quarter ended March 31, 2013, and includes a press release as Exhibit 99.1 with financial results. The document length is 2705 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or substantive analysis itself. According to the 'Menu vs Meal' rule, such a short document that references an attached press release for financial results should be classified as an Earnings Release (ER) since it is the initial announcement of quarterly financial results. The document is not a full quarterly report (IR) or annual report (10-K), nor is it a certification or regulatory filing fallback. Therefore, the best classification is Earnings Release (ER) with high confidence.
2013-05-03 English
FORM 4
Director's Dealing
2013-04-02 English
FORM 4
Director's Dealing
2013-03-18 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.